| 000 | 01152 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518045615.0 | ||
| 264 | 0 | _c20200915 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1464-3391 | ||
| 024 | 7 |
_a10.1016/j.bmc.2019.06.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNarramore, Sarah | |
| 245 | 0 | 0 |
_aNew insights into the binding mode of pyridine-3-carboxamide inhibitors of E. coli DNA gyrase. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry _c08 2019 |
||
| 300 |
_a3546-3550 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aDNA Gyrase _xgenetics |
| 650 | 0 | 4 |
_aEscherichia coli _xmetabolism |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTopoisomerase II Inhibitors _xpharmacology |
| 700 | 1 | _aStevenson, Clare E M | |
| 700 | 1 | _aMaxwell, Anthony | |
| 700 | 1 | _aLawson, David M | |
| 700 | 1 | _aFishwick, Colin W G | |
| 773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 27 _gno. 16 _gp. 3546-3550 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2019.06.015 _zAvailable from publisher's website |
| 999 |
_c29853533 _d29853533 |
||